407 related articles for article (PubMed ID: 26633369)
21. [Preventing adverse obstetric outcome in women with thrombophilia].
Verspyck E
Ann Med Interne (Paris); 2003; 154(5-6):366-9. PubMed ID: 15027592
[TBL] [Abstract][Full Text] [Related]
22. Successful pregnancy outcome in women with bad obstetric history and recurrent fetal loss due to thrombophilia: effect of unfractionated heparin and low-molecular weight heparin.
Ghosh K; Shetty S; Vora S; Salvi V
Clin Appl Thromb Hemost; 2008 Apr; 14(2):174-9. PubMed ID: 18160603
[TBL] [Abstract][Full Text] [Related]
23. Recurrent miscarriage and thrombophilia: an update.
McNamee K; Dawood F; Farquharson R
Curr Opin Obstet Gynecol; 2012 Aug; 24(4):229-34. PubMed ID: 22729089
[TBL] [Abstract][Full Text] [Related]
24. Outcomes in an obstetrical population with hereditary thrombophilia and high tobacco use.
Calhoun B; Hoover E; Seybold D; Broce M; Hill A; Schaible B; Bracero LA
J Matern Fetal Neonatal Med; 2018 May; 31(10):1267-1271. PubMed ID: 28367651
[TBL] [Abstract][Full Text] [Related]
25. Anticoagulation in pregnancy complications.
Middeldorp S
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):393-9. PubMed ID: 25696884
[TBL] [Abstract][Full Text] [Related]
26. Recurrence rate of pre-eclampsia in women with thrombophilia influenced by low-molecular-weight heparin treatment?
Kalk JJ; Huisjes AJ; de Groot CJ; van Beek E; van Pampus MG; Spaanderman ME; van Eyck J; Oei SG; Bezemer PD; de Vries JI
Neth J Med; 2004 Mar; 62(3):83-7. PubMed ID: 15209472
[TBL] [Abstract][Full Text] [Related]
27. Understanding and Preventing Placenta-Mediated Pregnancy Complications.
Skeith L; Blondon M; Ní Áinle F
Hamostaseologie; 2020 Aug; 40(3):356-363. PubMed ID: 32726830
[TBL] [Abstract][Full Text] [Related]
28. Thromboprophylaxis implementation during pregnancy in women with recurrent foetal losses and thrombophilia.
Mitić G; Novakov Mikić A; Povazan L; Mitreski A; Kopitović V; Vejnović T
Med Pregl; 2011; 64(9-10):471-5. PubMed ID: 22097113
[TBL] [Abstract][Full Text] [Related]
29. Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.
de Vries JI; van Pampus MG; Hague WM; Bezemer PD; Joosten JH;
J Thromb Haemost; 2012 Jan; 10(1):64-72. PubMed ID: 22118560
[TBL] [Abstract][Full Text] [Related]
30. The role of aspirin, heparin, and other interventions in the prevention and treatment of fetal growth restriction.
Groom KM; David AL
Am J Obstet Gynecol; 2018 Feb; 218(2S):S829-S840. PubMed ID: 29229321
[TBL] [Abstract][Full Text] [Related]
31. Testing for inherited thrombophilia in recurrent miscarriage.
de Jong PG; Goddijn M; Middeldorp S
Semin Reprod Med; 2011 Nov; 29(6):540-7. PubMed ID: 22161466
[TBL] [Abstract][Full Text] [Related]
32. Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
Riyazi N; Leeda M; de Vries JI; Huijgens PC; van Geijn HP; Dekker GA
Eur J Obstet Gynecol Reprod Biol; 1998 Sep; 80(1):49-54. PubMed ID: 9758259
[TBL] [Abstract][Full Text] [Related]
33. Thrombophilia and pregnancy complications: cause or association?
Middeldorp S
J Thromb Haemost; 2007 Jul; 5 Suppl 1():276-82. PubMed ID: 17635737
[TBL] [Abstract][Full Text] [Related]
34. Preventing thrombophilia-related complications of pregnancy: an update.
Bates SM
Expert Rev Hematol; 2013 Jun; 6(3):287-300. PubMed ID: 23782083
[TBL] [Abstract][Full Text] [Related]
35. [Our experience with management of inherited thrombophilia during pregnancy: preliminary report].
Marinov B; Pramatarova T; Andreeva A; Iarukova N; Slavov A
Akush Ginekol (Sofiia); 2011; 50 Suppl 2():28-31. PubMed ID: 22524136
[TBL] [Abstract][Full Text] [Related]
36. [Our experience with management of inherited thrombophilia during pregnancy. Preliminary report].
Marinov B; Pramatarova T; Andreeva A; Iarukova N; Slavov A
Akush Ginekol (Sofiia); 2011; 50(6):15-7. PubMed ID: 22452061
[TBL] [Abstract][Full Text] [Related]
37. Thrombophilia and fetal loss.
Brenner B
Semin Thromb Hemost; 2003 Apr; 29(2):165-70. PubMed ID: 12709919
[TBL] [Abstract][Full Text] [Related]
38. Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies.
Deruelle P; Denervaud M; Hachulla E; Ducloy-Bouthors AS; Valat AS; Puech F; Trillot N; Hatron PY; Subtil D
Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):73-8. PubMed ID: 16242833
[TBL] [Abstract][Full Text] [Related]
39. Low molecular weight heparin treatment and impact of inherited thrombophilia type in pregnancies with previous adverse outcome.
Aracic N; Roje D; Drmic Hofman I; Capkun V; Stefanovic V
J Matern Fetal Neonatal Med; 2015 Feb; 28(3):306-10. PubMed ID: 24749801
[TBL] [Abstract][Full Text] [Related]
40. High frequency of congenital thrombophilia in women with pathological pregnancies?
Rasmussen A; Ravn P
Acta Obstet Gynecol Scand; 2004 Sep; 83(9):808-17. PubMed ID: 15315591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
